---
title: Robust Stable Line Platform for Biologics Development
---

[![BPI Media_Logo 2_Color 1](https://bpi.bioprocessintl.com/hs-fs/hubfs/BPI%20Media_Logo%202_Color%201.png?width=350&height=161&name=BPI%20Media_Logo%202_Color%201.png)](https://bioprocessintl.com/)

## ![New-ATE-Logo2019](https://bpi.bioprocessintl.com/hs-fs/hubfs/New-ATE-Logo2019.png?width=700&name=New-ATE-Logo2019.png)

### Robust Stable Line Platform for Biologics Development

 Please join us for this Ask the Expert webcast.

Just fill out the form below to register.

|  |
| --- |

## Presenters:

**![Sean](https://bpi.bioprocessintl.com/hs-fs/hubfs/Sean.jpg?width=146&name=Sean.jpg)**

**Dr. Sean Liour**

**Vice President for Project Management, GenScript ProBio**

 

Dr. Liour is the VP for Project Management at GenScript ProBio and has 10 years of experience in biologics development. He has worked at Fountain Biopharma, leading projects to preclinical CMC, PK/PD study, FDA IND filing, and clinical phases I and II. He also worked at Henlius in 2016, leading development, IND filing, and NDA filing.

 

 

## About this event:

#### Date: March 18, 2020

#### Time: 11 am EST | 8 am PST |             4 pm CET

#### Duration: 15 minutes

- A cell line platform can provide the best solution for the biopharmaceutical target.
- This webinar explains how to develop a robust stable line platform for CMC projects.
- GenScript’s biologics platform can provide one-stop service of CMC for the biopharmaceutical target.

-  

-  

©2015 BioProcess International All Rights reserved